INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Dr. (Ms.) Vasudha V. Kamat as an Additional Independent Director of the Company25-03-2020
25-03-2020
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliance under Regulation 47 (LODR) - Newspaper Advertisements - Unaudited Financial Results for the Third Quarter and Nine Months ended 31st December, 201929-01-2020
Broker's call: Indoco Remedies (Sell)
India NiveshIndoco Remedies (Sell)CMP: 223.1Target: 100Indoco reported an in-line Q3, with sales growth of 14 per cent y-o-y and EBITDA margins at 125-01-2020
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Meeting Updates
Management Discussion & Analysis for the Third Quarter ended 31/12/201923-01-2020
Indoco Remedies Ltd - 532612 - Unaudited Results 31.12.2019
Unaudited Financial Results for the quarter ended 31.12.201923-01-2020
INDOCO REMEDIES LTD. - 532612 - Clarification
With reference to Movement in Volume, Indoco Remedies Ltd has submitted to BSE a copy of Clarification is enclosed.21-01-2020
INDOCO REMEDIES LTD. - 532612 - Clarification sought from Indoco Remedies Ltd
The Exchange has sought clarification from Indoco Remedies Ltd on January 21, 2020, with reference to Movement in Volume. The reply is awaited.21-01-2020
Indoco Remedies Ltd - 532612 - Regulation 30 Of SEBI (LODR) Regulations,2015
Schedule of Con Call Meeting15-01-2020
Indoco Remedies Ltd - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under 74(5) of SEBI (DP) Regulations 201808-01-2020
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended December 31, 2019
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here07-01-2020